We evaluated the immunogenicity and safety of pentavalent human-bovine reassortant rotavirus vaccine in 178 Korean healthy infants. Seroresponse rate for serum antirotavirus IgA titers was 94.7% among 94 vaccine recipients, as compared with 13.5% among 52 placebo recipients. Seroresponse rates in serum neutralizing antibody to each human rotavirus serotype in the vaccine were significantly higher in the vaccine group than in the placebo group. This vaccine was generally well tolerated and immunogenic.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1097/INF.0b013e31815aba79 | DOI Listing |
Publication Analysis
Top Keywords
immunogenicity safety
8
safety pentavalent
8
pentavalent human-bovine
8
reassortant rotavirus
8
rotavirus vaccine
8
healthy infants
8
vaccine
6
human-bovine wc3
4
wc3 reassortant
4
vaccine healthy
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!